2013 American Transplant Congress
Minimization of Immunosuppression for ABO-Incompatible Kidney Transplantation Based on the Strength of Pretreatment Anti A/B Antibody Titer
Acute antibody mediated rejection (AMR) used to be a major problem in ABO-incompatible KidneyTransplantation (ABOi-KTx), and currently rituximab has been accepted to reduce the prevalence…2013 American Transplant Congress
Conversion from Tacrolimus to Sirolimus May Increase the Risk of Cardiovascular Events in Kidney Transplant Recipients
Beth Israel Deaconess Medical Center, Boston, MA
Sirolimus (SRL) based immunosuppression regimens are used in kidney transplant recipients (KTRs) to avoid tacrolimus (TAC) toxicity. KTRs have a high risk of cardiovascular events…2013 American Transplant Congress
Identification of Common Blood-Based Biomarker Gene Panels for the Diagnosis of Renal and Cardiac Acute Allograft Rejection
To validate a peripheral blood transcriptional biomarker panel diagnostic for acute renal allograft rejection for the diagnosis and prediction of acute cardiac allograft rejection we…2013 American Transplant Congress
Effective Federal Advocacy: The Case for HIV-Infected Deceased Organ Donors
Johns Hopkins, Baltimore; UCSF, San Francisco
Background. HIV is no longer a contraindication to solid organ transplantation. For HIV-infected patients, HIV-infected deceased donors (HIVDD) could attenuate the organ shortage and waitlist…2013 American Transplant Congress
Incidence of BKV after Kidney Transplantation with Tacrolimus (FK) Based Immunosuppression and Alemtuzumab Induction: A Retrospective Analysis of Donation after-Cardiac Death (DCD) vs. Donation after Brain Death (DBD)
Introduction: With increasing organ shortage, transplant centers are increasing the utilization of DCD organs. However, the incidence of BKV has not been well investigated when…2013 American Transplant Congress
Gradual vs Rapid Withdrawal of Immunosuppression after Kidney Allograft Failure Results in Less Allosensitization, Decreased Rate of De-Novo Donor Specific Antibody and Reduced Need for Allograft Nephrectomy
Aim- Allosensitization after renal allograft failure is a major obstacle to re-transplantation.Withdrawal of immunosuppression after allograft failure is associated with sensitization. However, prolonged continuation of…2013 American Transplant Congress
Efficient Identification of All Grades of Antibody Mediated Rejection (AMR) and Mixed Rejection with a Unique Immunohistochemical Panel in Heart Transplant Patients
Antibody Mediated Rejection (AMR) following heart transplantation is increasingly recognized as a substantial complication that increases risk for graft failure, vasculopathy, and decreased recipient survival.…2013 American Transplant Congress
Pulmonary Vascular Hemodynamics Improvement with Left Ventricular Assist Devices Unloading Is Sustained after Heart Transplantation
UTAH Cardiac Transplant Program, Salt Lake City, UT
Background:Pulmonary hypertension (PHT) is frequently seen in patients with advanced heart failure (HF) awaiting heart transplantation (HTx). Severe PHT is a contraindication for HTx. Both…2013 American Transplant Congress
Long-Term Persistence of Recipient MHC Class-II Antigen Following Allogeneic Bone Marrow Transplantation
Surgery, Duke University, Durham, NC; Medicine and Immunology, Duke University, Durham, NC
Background: Following allogeneic bone marrow transplantation there is rapid replacement of host antigen presenting cells with donor antigen presenting cells. This has important implications of…2013 American Transplant Congress
Sustained Expression of CD39 Protects Acutely from Renal IRI but Promotes Fibrosis
Background: The adenosinergic axis is involved in renal ischemia reperfusion injury (IRI) and the generation of adenosine by the action of CD39 and CD73 is…
- « Previous Page
- 1
- …
- 13
- 14
- 15
- 16
- 17
- …
- 178
- Next Page »